Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer

Carcinogenesis

Volumn 36, Issue 9, 2015, Pages 999-1007

  Khalili, Hamed ^a   Gong, Jian ^b   Brenner, Hermann ^c   Austin, Thomas R ^d   Hutter, Carolyn M ^e   Baba, Yoshifumi ^f   Baron, John A ^g   Berndt, Sonja I ^e   Bézieau, Stéphane ^h   Caan, Bette ⁱ   Campbell, Peter T ^j   Chang Claude, Jenny ^c   Chanock, Stephen J ^e   Chen, Constance ^k   Hsu, Li ^b   Jiao, Shuo ^b   Conti, David V ^l   Duggan, David ^m   Fuchs, Charles S ^n,o   Gala, Manish ^a   Gallinger, Steven ^p   Haile, Robert W ^q   Harrison, Tabitha A ^b   Hayes, Richard ^r   Hazra, Aditi ^o   Henderson, Brian ^l   Haiman, Chris ^l   Hoffmeister, Michael ^c   Hopper, John L ^s   Jenkins, Mark A ^r   Kolonel, Laurence N ^t   Küry, Sébastien ^h   LaCroix, Andrea ^b   Le Marchand, Loic ^t   Lemire, Mathieu ^u   Lindor, Noralane M ^v   Ma, Jing ^o   Manson, JoAnn E ^w   Morikawa, Teppei ^x   Nan, Hongmei ^o   Ng, Kimmie ⁿ   Newcomb, Polly A ^b   Nishihara, Reiko ^k,n   Potter, John D ^b,y,z   Qu, Conghui ^b   Schoen, Robert E ^aa   Schumacher, Fredrick R ^l   Seminara, Daniela ^e   Taverna, Darin ^m   Thibodeau, Stephen ^ab   Wactawski Wende, Jean ^ac   White, Emily ^b   Wu, Kana ^k   Zanke, Brent W ^ad   Casey, Graham ^l   Hudson, Thomas J ^u,ae   Kraft, Peter ^k,o   Peters, Ulrike ^b   Slattery, Martha L ^af   Ogino, Shuji ^k,n,w   Chan, Andrew T ^a,o   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d WHITMAN COLLEGE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f KUMAMOTO UNIVERSITY   (Japan)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j AMERICAN CANCER SOCIETY   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m Systems Imagination   (United States)

ⁿ DANA FARBER CANCER INSTITUTE   (United States)

^o INDIANA UNIVERSITY   (United States)

^p TORONTO GENERAL HOSPITAL   (Canada)

^q STANFORD CANCER INSTITUTE   (United States)

^r NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF MELBOURNE   (Australia)

^t UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^u ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^v MAYO CLINIC   (United States)

^w BRIGHAM AND WOMEN S HOSPITAL   (United States)

^x UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^y UNIVERSITY OF WASHINGTON   (United States)

^z MASSEY UNIVERSITY   (New Zealand)

^aa UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^ab MAYO CLINIC   (United States)

^ac UNIVERSITY AT BUFFALO   (United States)

^ad OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^ae UNIVERSITY OF TORONTO   (Canada)

^af UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CHEMOKINE RECEPTOR CXCR2; K RAS PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR CDX2; MICROSATELLITE DNA;

ALLELE; ARTICLE; CANCER RISK; CHROMOSOME 11; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; CAUCASIAN; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; RISK;

COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84940654101     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv086     Document Type: Article

References (50)

1. Ullman, T.A. et al. (2011) Intestinal inflammation and cancer. Gastroenterology, 140, 1807-1816.
2. Aust, D.E. et al. (2002) The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer, 94, 1421-1427.
3. Bass, A.J. et al. (2011) Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat. Genet., 43, 964-968.
4. Itzkowitz, S.H. et al. (2005) Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm. Bowel Dis., 11, 314-321.
5. Jostins, L. et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491, 119-124.
6. Anderson, C.A. et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet., 43, 246-252.
7. Franke, A. et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet., 42, 1118-1125.
8. Elliott, M. et al. (2009) Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann. N. Y. Acad. Sci., 1182, 97-110.
9. Sandborn, W.J. et al.; Ustekinumab Crohn's Disease Study Group. (2008) A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology, 135, 1130-1141.
10. Sandborn, W.J. et al.; CERTIFI Study Group. (2012) Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N. Engl. J. Med., 367, 1519-1528.
11. Newcomb, P.A. et al.; Colon Cancer Family Registry. (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol. Biomarkers Prev., 16, 2331-2343.
12. Peters, U. et al. (2012) Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet., 131, 217-234.
13. McGovern, D.P. et al.; NIDDK IBD Genetics Consortium. (2010) Genomewide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet., 42, 332-337.
14. Chan, A.T. et al. (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA, 302, 649-658.
15. Ogino, S. et al. (2006) Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod. Pathol., 19, 59-68.
16. Ogino, S. et al. (2009) Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin. Cancer Res., 15, 6412-6420.
17. Ogino, S. et al. (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J. Mol. Diagn., 8, 209-217.
18. Nosho, K. et al. (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One, 3, e3698.
19. Ogino, S. et al. (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J. Mol. Diagn., 9, 305-314.
20. Ogino, S. et al. (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut, 58, 90-96.
21. Ogino, S. et al. (2005) Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J. Mol. Diagn., 7, 413-421.
22. Morikawa, T. et al. (2012) Tumor TP53 expression status, body mass index and prognosis in colorectal cancer. Int. J. Cancer, 131, 1169-1178.
23. Baba, Y. et al. (2009) Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin. Cancer Res., 15, 4665-4673.
24. Samowitz, W.S. et al. (2002) Prognostic significance of p53 mutations in colon cancer at the population level. Int. J. Cancer, 99, 597-602.
25. Slattery, M.L. et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl. Cancer Inst., 92, 1831-1836.
26. Slattery, M.L. et al. (2007) Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int. J. Cancer, 120, 656-663.
27. Samowitz, W.S. et al. (2000) Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol. Biomarkers Prev., 9, 1193-1197.
28. Jiao, S. et al. (2011) The use of imputed values in the meta-analysis of genome-wide association studies. Genet. Epidemiol., 35, 597-605.
29. Ioannidis, J.P. et al. (2007) Heterogeneity in meta-analyses of genomewide association investigations. PLoS One, 2, e841.
30. Purcell, S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
31. Mogoanta, SS et al. (2014) Peritumoral inflammatory reaction in colon cancer. Histological and immunohistochemical study. Rom. J. Morphol. Embryol., 55, 1429-1435.
32. Morikawa, T. et al. (2011) STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers. Clin. Cancer Res., 17, 1452-1462.
33. Katoh, H. et al. (2013) CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell, 24, 631-644.
34. Jamieson, T. et al. (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest., 122, 3127-3144.
35. Ishitsuka, T. et al. (2001) Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis. J. Clin. Pathol., 54, 526-532.
36. Cravo, M.L. et al. (1998) Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am. J. Gastroenterol., 93, 2060-2064.
37. Brentnall, T.A. et al. (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 56, 1237-1240.
38. Lyda, M.H. et al. (1998) Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology, 115, 1566-1573.
39. Hofseth, L.J. et al. (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J. Clin. Invest., 112, 1887-1894.
40. Zeller, T. et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One, 5, e10693.
41. Kjer-Nielsen, L. et al. (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature, 491, 717-723.
42. Reantragoon, R. et al. (2012) Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med., 209, 761-774.
43. Lion, J. et al. (2013) MR1B, a natural spliced isoform of the MHC-related 1 protein, is expressed as homodimers at the cell surface and activates MAIT cells. Eur. J. Immunol., 43, 1363-1373.
44. Young, M.H. et al. (2013) Mucosal associated invariant T cells: don't forget your vitamins. Cell Res., 23, 460-462.
45. Martin, E. et al. (2009) Stepwise development of MAIT cells in mouse and human. PLoS Biol., 7, e54.
46. Sears, C.L. et al. (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe, 15, 317-328.
47. Chan AT et al. (2010) Primary prevention of colorectal cancer. Gastroenterology, 138, 2029-2043.
48. Kostic, A.D. et al. (2014) The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology, 146, 1489-1499.
49. Phipps, AI et al. (2012) Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology, 143, 51-54.
50. Ogino, S. et al. (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut, 60, 397-411.